A Study to Characterize the Pharmacokinetics/Pharmacodynamics and Effect of Food of DA-1229 in Healthy Male Subjects

NCT00961025 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitis Type 2

Interventions

DRUG: DA-1229
DRUG: Placebo

Sponsor

Dong-A Pharmaceutical Co., Ltd.